Proteins in Pharmacology: Restrictions, Challenges and Opportunities

Author(s): Andrey A. Zamyatnin.

Journal Name: Current Medicinal Chemistry

Volume 26 , Issue 3 , 2019

Become EABM
Become Reviewer

[1]
Kopertekh, L.; Schiemann, J. Transient production of recombinant pharmaceutical proteins in plants: Evolution and perspectives. Curr. Med. Chem., 2019, 26(3), 365-380.
[2]
Komarova, T.V.; Sheshukova, E.V.; Dorokhov, Yu.L. Plant-made antibodies: Properties and therapeutic applications. Curr. Med. Chem., 2019, 26(3), 381-395.
[3]
Kholodenko, R.V.; Kalinovsky, D.V.; Doronin, I.I.; Ponomarev, E.D.; Kholodenko, I.V. Antibody fragments as potential biopharmaceuticals for cancer therapy: success and limitations. Curr. Med. Chem., 2019, 26(3), 396-426.
[4]
Baldin, A.V.; Zamyatnin, A.A., Jr; Bazhin, A.V.; Xue, W.H.; Savvateeva, L.V. Advances in the development of anticancer hsp-based vaccines. Curr. Med. Chem., 2019, 26(3), 427-445.
[5]
Pokrovsky, V.S.; Chepikova, O.E.; Davydov, D.Zh.; Zamyatnin, A.A., Jr; Lukashev, A.N.; Lukasheva, E.V. Amino acid degrading enzymes and their application in cancer therapy. Curr. Med. Chem., 2019, 26(3), 446-464.
[6]
Balakireva, A.V.; Kuznetsova, N.V.; Petushkova, A.I.; Savvateeva, L.V.; Zamyatnin, A.A., Jr Trends and prospects of plant proteases in therapeutics. Curr. Med. Chem., 2019, 26(3), 465-486.
[7]
Shekhter, A.B.; Balakireva, A.V.; Kuznetsova, N.V.; Vukolova, M.N.; Litvitsky, P.F.; Zamyatnin, A.A., Jr Collagenolytic enzymes and their applications in biomedicine. Curr. Med. Chem., 2019, 26(3), 487-505.
[8]
Shekhter, A.B.; Fayzullin, A.L.; Vukolova, M.N.; Rudenko, T.G.; Osipycheva, V.D.; Litvitsky, P.F. Medical applications of collagen and collagen-based materials. Curr. Med. Chem., 2019, 26(3), 506-516.
[9]
Zernii, E.Y.; Baksheeva, V.E.; Yani, E.V.; Philippov, P.P.; Senin, I.I. Therapeutic proteins for treatment of corneal epithelial defects. Curr. Med. Chem., 2019, 26(3), 517-545.
[10]
Fetissov, S.O.; Legrand, R.; Lucas, N. Bacterial protein mimetic of peptide hormone as a new class of protein-based drugs. Curr. Med. Chem., 2019, 26(3), 546-553.
[11]
Syrkina, M.S.; Vassetzky, Y.S.; Rubtsov, M.A. MUC1 story: great expectations, disappointments and the renaissance. Curr. Med. Chem., 2019, 26(3), 554-563.
[12]
Orlov, S.N.; La, J.; Smolyaninova, L.V.; Dulin, N.O. Na+,K+-ATPase as a target for treatment of tissue fibrosis. Curr. Med. Chem., 2019, 26(3), 564-575.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 26
ISSUE: 3
Year: 2019
Page: [362 - 364]
Pages: 3
DOI: 10.2174/092986732603190326151415

Article Metrics

PDF: 17
HTML: 3